Aims: The ethanol metabolites ethyl glucuronide (EtG) and ethyl sulphate (EtS) are detectable for longer in urine than breath ethanol or urine ethanol after alcohol intake. This study compared the performance of breath ethanol, urine ethanol, urine EtG and EtS to detect alcohol consumption in clients in community alcohol treatment. Methods: Clients attending the community alcohol treatment programme were asked to provide an alcohol diary, breathalyser test and urine for ethanol, EtG and EtS measurement (n = 42). Positive results were defined using the detection limits (breath ethanol and urine ethanol) or clinical cut-offs (EtG: 0.26 mg/L and EtS: 0.22 mg/L). The sensitivities and specificities of each marker to detect alcohol intake <24 and 48-72 h prior were calculated. Results: The sensitivities of each alcohol marker to detect alcohol intake <24 h prior were 57, 71, 100 and 100% for breath ethanol, urine ethanol, urine EtG and urine EtS, respectively. The specificity was 100% for urine ethanol and urine EtS. The EtG specificity could be increased to 100% by using a higher cut-off (0.50 mg/L). The sensitivity of all markers (including EtG and EtS) to detect alcohol intake of ≤10 units 48-72 h earlier decreased to 0%. Conclusions: In community alcohol treatment clients, urine EtG and EtS showed the optimum diagnostic performance to detect alcohol intake in the previous 24 h. We propose a flowchart to routinely use EtG and EtS for clients in community alcohol treatment. Short summary: The ability of breath ethanol, urine ethanol, urine EtG and urine EtS to detect continued alcohol consumption in clients in community alcohol treatment were compared. Urine EtG and EtS showed the optimum diagnostic performance and we propose a flowchart to routinely use EtG and EtS in community alcohol treatment.
INTRODUCTION
The introduction of newer biochemical markers of alcohol intake that can improve the detection of continued alcohol use in clients with alcohol dependence could assist in increasing the number that successfully complete treatment. In 2013/14, only 38% of alcohol dependent clients in the UK successfully completed their treatment (Public Health England, 2014) . Reliance on self-reporting of alcohol intake makes assessment of progress difficult. Ethyl glucuronide (EtG) and ethyl sulphate (EtS) are ethanol metabolites and their clinical use is to increase the time window for detecting alcohol ingestion. Following the ingestion of ethanol, over 95% is metabolized in the liver by alcohol dehydrogenase to acetaldehyde then by aldehyde dehydrogenase to acetic acid (Porter, 2008) . Less than 5% of ethanol is excreted unchanged in the urine, breath and sweat. A small amount of ethanol (<0.1%) is conjugated to form EtG and EtS. The time window of detection after consuming alcohol may be up to 4-6 h for breath ethanol, up to 12 h for urine ethanol and up to 130 h for urine EtG and EtS depending on the amount of alcohol consumed (Helander et al., 1996; Dahl et al., 2002; Helander and Beck, 2005; Jones, 2008; Helander et al., 2009 ). However, a detection time window of 130 h has only been observed in patients admitted for alcohol detoxification after heavy consumption. Following smaller amounts of alcohol consumption, the sensitivity of EtG and EtS to detect alcohol intake is excellent up to 24 h but the detection rate decreases by 48 h (Jatlow et al., 2014) . Previous studies using urine EtG and EtS measurements to detect continued alcohol use in clients in alcohol treatment programmes have demonstrated the benefit in measuring urine EtG and EtS to identify clients that claim to be abstaining from alcohol but are still continuing to drink (Junghanns et al., 2009; Dahl et al., 2011) . For example, in one study 8.5% of urine samples were found to be positive for urine EtG/EtS in clients that had declared no alcohol consumption. However, these have included small numbers of alcohol dependent clients (n = 8) or included clients post alcohol detoxification. There have been no published studies of the use of these markers in community alcohol treatment programmes within the UK.
False positive and false negative EtG results have been reported due to bacterial contamination of urine samples but EtS is not affected so the EtS result can verify whether the EtG is a true positive or a true negative (Helander and Dahl, 2005; Helander et al., 2007) . False positive EtG but not EtS results have also been reported following the use of ethanol based hand gels (Reisfield et al., 2011a) . Detectable EtG and EtS results are also possible following the use of ethanol based mouthwash. However, results are unlikely to be above the cut-offs with mouthwash use at the recommended frequency (Reisfield et al., 2011b) . Certain non-alcoholic beers do contain a small amount of alcohol (up to 0.5%) and a study where volunteers consumed 2.5 L of 0.5% beer indicated that this could cause low positive EtG but not EtS results in a urine sample collected the following morning (Thierauf et al., 2010) . To remove the possibility of false negative ethanol, EtG and EtS results after the consumption of large amounts of water, it is prudent to also measure creatinine in the urine (Dahl et al., 2002) . Table 1 summarizes the possible causes of EtG and EtS results above and below the cut-offs.
Suitable cut-offs for urine EtG and EtS are still widely debated. Some authors have advocated the use of a higher cut-off for EtG (0.50 mg/L) to reduce the risk of false positives. However, this decreases the sensitivity to detect alcohol consumption so other authors have proposed a cut-off of 0.20 mg/L to optimize the sensitivity and specificity to detect recent alcohol consumption (Lowe et al., 2015) . SAMHSA have recommended using different EtG cutoffs depending on the clinical scenario: 0.10 mg/L for total abstinence and 1.0 mg/L to confirm alcohol consumption with results between 0.10 and 1.0 mg/L consistent with unintentional alcohol exposure or alcohol consumption (SAMHSA, 2012 ). An EtS cut-off of 0.10 mg/L has been suggested. Cut-offs have also been defined by recruiting non-drinkers and measuring EtG and EtS. A recent study that recruited 81 patients who had not consumed alcohol for at least 2 weeks calculated cut-offs (incorporating measurement uncertainty) for EtG and EtS of 0.26 and 0.22 mg/L, respectively (Armer and Allcock, 2016) . Cut-offs defined using a large non-drinking population may be more clinically relevant than using arbitrary cut-offs selected to try and reduce the number of positive results due to unintentional ethanol exposure.
The aim of this study was to compare the ability of breath ethanol, urine ethanol, urine EtG and urine EtS to detect alcohol consumption in clients in a UK community alcohol treatment programme compared to self-report using an alcohol diary. Clients starting the 12-week community alcohol treatment programme at the Alcohol Recovery Service in Central Lancashire were recruited over 1 year (see Supplementary Figure 1 for the full study protocol). All participants provided written informed consent prior to inclusion in the study. If clients did not attend for one or more of the sample collection weeks, they were still able to continue to participate for later weeks within the study protocol.
MATERIALS AND METHODS

Study participants
Of all, 31 clients agreed to participate (out of 95 clients invited to participate). In total, 110 samples were collected but only 42 sets of samples were provided with a completed alcohol diary. The 18 participants providing paired diaries and samples had an average age of 44 years (range: 29-61 years) and 11 were male (61%).
The blood and urine samples were analysed in the Biochemistry Department at the Royal Preston Hospital. The alcohol diary, request form and samples were labeled with the participant's study number only. On arrival in the laboratory, the following tests were performed immediately: urine ethanol and urine creatinine. These results were recorded electronically on the laboratory information system against the study number only. The remaining urine was stored frozen at −20°C prior to analysis for EtG and EtS.
Analysis of alcohol markers
Urine EtG and EtS were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) in the negative ionisation mode. The analysis was performed using selected ion monitoring at m/z 221.2 and 226.1 for EtG and the deuterated internal standard EtG-d5 and at 125.1 and 130.1 for EtS and the deuterated standard EtS-d5. The lower limit of quantitation for this method is 0.20 mg/L (CV = 6%) and 0.04 mg/L (CV = 7%) for EtG and EtS, respectively. The measuring ranges are 0.20-205 mg/L and 0.04-82 mg/L for EtG and EtS, respectively. This method has been previously validated and the clinical cut-offs of 0.26 mg/L and 0.22 mg/L for EtG and EtS, respectively were defined in a large non-drinking population (Armer and Allcock, 2016) . Breath ethanol was measured using the Lion Alcolmeter500 breathalyser (Lion Laboratories, Barry, UK) which is used routinely by the local Alcohol Recovery Service team. Urine ethanol was determined by the alcohol dehydrogenase method on the Roche Cobas 8000 (Roche Diagnostics, Burgess Hill, UK). The detection limit for breath ethanol and urine ethanol are 0.02 and 100 mg/L, respectively. Urine creatinine was measured by the enzymatic method (creatininase, creatinase, sarcosine oxidase and peroxidase) on the Roche Cobas 8000 (Roche Diagnostics, Burgess Hill, UK) and used for validity testing of samples (European Workplace Drug Testing Society, 2015) .
Statistical analysis
The alcohol diaries were separated into time windows to define whether the participant had been drinking or not drinking. If alcohol had been consumed in a time window, the number of units consumed was calculated. Each alcohol marker was defined as 'positive' or 'negative' using the detection limit (breath ethanol and urine ethanol) or the clinical cut-offs (EtG and EtS). The alcohol diaries were divided into individual time windows (previous 24 h, previous 24-48 h and previous 48-72 h) and the number of UK units (1 unit = 10 mL or 8 g of pure alcohol) consumed in each time window was calculated. The total number of alcohol units consumed in the previous 72 h was also calculated. The sensitivities and specificities of each marker to detect alcohol intake within each time window were calculated. Any participants that had consumed alcohol prior to the 24-48 or 48-72 h time windows were excluded from the calculations. For EtG, two cut-offs were compared: 0.26 and 0.50 mg/L. To assess the validity of the diaries, urine EtS was used as a gold standard.
RESULTS
A total of 42 alcohol diaries were received from participants; 10 diaries recorded alcohol consumption in the previous 72 h of up to 93 units. The remaining 32 diaries recorded alcohol abstinence in the previous 72 h. Creatinine was <2 mmol/L in 5/40. (The results for all participants and their alcohol intake are available in Supplementary Table 1) The sensitivities and specificities of each alcohol marker for the detection of alcohol intake in the previous 24 h are shown in Fig. 1 . The sensitivities to detect alcohol intake in the previous 24 h were 57, 71, 100 and 100% for breath ethanol, urine ethanol, urine EtG (both cut-offs) and urine EtS, respectively. The specificity of all alcohol markers was ≥94%. All the alcohol markers had excellent specificities for the detection of recent alcohol intake. The higher specificity of urine EtS compared to urine EtG may be due to there being another cause of the positive EtG results when using the cutoff of 0.26 mg/L rather than being due to recent alcohol consumption (Table 1) . For EtG, the detection of non-drinkers increased to 100% if the higher cut-off of 0.50 mg/L was used.
Sensitivities and specificities could not be calculated for the 24-48 h time window as all participants that had consumed alcohol in that time window had also consumed alcohol in the previous 24 h.
For the 48-72 h time window, three participants had consumed alcohol in this time window only. The three participants had negative results for all alcohol markers so the sensitivity was 0% for all alcohol markers. The specificity (no alcohol in the previous 72 h) was 100% for urine ethanol, urine EtG and urine EtG. The specificity for breath ethanol was 97%.
To determine the validity of the alcohol diaries, EtS results were used as the gold standard. There were seven positive EtS results (cutoff: 0.22 mg/L) with seven diaries demonstrating alcohol intake so the sensitivity was 100%. The specificity of the diaries was 100%; all negative EtS results were paired with a diary stating alcohol abstinence.
DISCUSSION
This study has compared four alcohol markers to detect selfreported alcohol consumption in clients in a community alcohol treatment programme. All four alcohol markers had excellent specificity. The sensitivity to detect alcohol intake in the previous 24 h was the lowest for breath ethanol (57%) and the highest for urine EtG (100%) and EtS (100%) using the clinical cut-offs of 0.26 and 0.22 mg/L, respectively. The specificity of EtS was higher than for EtG. There has been much debate about the appropriate cut-offs for EtG. If a higher cut-off of 0.50 mg/L was adopted, the specificity of EtG would increase to 100%. A limitation of the individual time windows is that many participants had consumed alcohol in more than one time window so had to be excluded from the calculations for sensitivity and specificity. For example, alcohol consumption in the previous 24 h in addition to 48-72 h prior to sample collection is likely to lead to a positive result. It does not necessarily mean that the test can detect alcohol intake 48-72 h prior to sample collection. It was not possible to calculate the sensitivity and specificity of the alcohol markers to detect alcohol consumption in the 24-48 h time window only. All participants that only consumed alcohol in the 48-72 h time window had consumed ≤10 units (n = 3) and none of these participants had positive results for any of the markers. Therefore, the sensitivity to detect ≤10 units of alcohol consumption 48-72 h earlier was 0% for all alcohol markers. This is in agreement with previous studies; following the ingestion of <10 units of alcohol, EtG was not detectable in the majority of participants beyond 48 h (Jatlow et al., 2014) . Detectable EtG and EtS results beyond 48-72 h have only been demonstrated after very high levels of alcohol consumption (Helander et al., 1996; Dahl et al., 2002; Helander et al., 2009) . Use of individual time windows is difficult in alcohol dependent clients who may drink alcohol every day but is a useful tool when performing controlled alcohol intake experiments with subjects that are not alcohol dependent (Jatlow et al., 2014) .
In our study, all clients who had consumed alcohol in the previous 24 h had positive EtG and EtS results. The validity of 5/40 urine samples was questionable due to a low urine creatinine (<2 mmol/L). The EtG and EtS results on these clients were all consistent with their alcohol diaries. However, in routine use, these results should be interpreted with caution if negative as they may be false negatives due to a dilute urine sample.
The demographics of our participants were comparable to the Public Health England (2014) published statistics on clients in alcohol treatment (median age 43 years and 64% male). The small number recruited is comparable to other studies. For example, Dahl et al. (2011) recruited 24 patients and only 8 of these were undergoing treatment for alcohol dependence. Similarly to other studies involving participants in alcohol treatment, the number of samples collected decreased from 18 in week 1 to five samples in week 12 (Junghanns et al., 2009) . A limitation of this study is that only 10 diaries demonstrated alcohol consumption in the previous 72 h. However, the large number of abstinent patients has allowed us to demonstrate the excellent specificity of all four alcohol markers.
This study is in agreement with previously published studies demonstrating the high sensitivity and specificity of urine EtG and EtS to detect recent alcohol intake. Lowe et al. (2015) demonstrated a sensitivity of 84% and specificity of 83% to detect alcohol consumption after 48 h using an EtG immunoassay (cut-off: 0.15 mg/L). Jatlow et al. (2014) combined results from two clinical trials comparing urine EtG results to self-reported alcohol intake. Over 80% of those self-reporting alcohol consumption within the previous 24 h were identified using cut-offs of 0.10 or 0.20 mg/L. Only 75% were detected using the 0.50 mg/L cut-off. The detection rate was <40% for all cut-offs to detect alcohol consumption in the previous 25-48 h. Dahl et al. (2011) demonstrated a sensitivity of 80% for both EtG and EtS and specificities of 93 and 89% for EtG and EtS respectively to detect self-reported alcohol consumption in the last 3 days. In that study, 8.5% of clients had positive urine EtG/EtS results but reported no alcohol consumption. The sensitivity (100%) and specificity (100%) of urine EtG and EtS to detect alcohol consumption in the previous 24 h were higher in the present study than in the previously published studies, even though all relied on selfreporting of alcohol intake. This may be due to low numbers in our study, the use of different clinical cut-offs or the accuracy of the selfreported alcohol intake. We were unable to determine the sensitivity for the 24-48 h time window so cannot compare this time window to other studies.
In this study, the diaries were completed anonymously and passed directly onto a member of the study team so clients felt comfortable completing them accurately. This has been validated by the finding that compared to a positive EtS result, the diaries demonstrated 100% sensitivity and 100% specificity for alcohol intake. The majority of clients who claimed not to be drinking alcohol had negative results for all four markers with the exception of three clients. One participant provided a diary showing no alcohol consumption for the last 7 days but had a positive breathalyser ethanol result (0.10 mg/L). The urine sample collected at the same time showed urine ethanol <100 mg/L, EtG <0.20 mg/L and EtS 0.04 mg/L. All of these results are below the cut-offs. It is possible that this was an erroneous false positive result, e.g. after the very recent use of ethanol-containing mouthwash (Foglio-Bonda et al., 2015) . If this result was discounted, the specificity of the breath ethanol test would increase to 100%. Two participants claimed to have not consumed any alcohol in the previous 7 days prior to sample collection but had EtG results just above the clinical cut-off (0.34 mg/L and 0.29 mg/L). Both participants had results below the cut-offs for all other alcohol markers. This highlights the continued controversy over the EtG cut-off and the importance of measuring both EtG and EtS with the use of EtS as a confirmatory test. False positive EtG results have been reported in the literature and possible causes are listed in Table 1 . In both participants, EtS was below the cut-off (0.11 and 0.10 mg/L).
In this study, more participants that were recently drinking were detected using the breathalyser (57%) than in other studies (Lande and Marin, 2013; Wetterling et al., 2014) . For example, in one study only 7% of those continuing to drink alcohol were detected using the breathalyser or self-reporting. This may be due to the use of different breathalysers or reflect the more recent alcohol consumption of our study participants.
Breath ethanol is used routinely to detect alcohol intake in clients attending the community alcohol treatment programme. Many clients that are continuing to drink alcohol will not be detected using a breathalyser test (up to 93% depending on the study) unless they admitted drinking alcohol in their diary. In this study, urine EtG and EtS were positive in all participants that had consumed alcohol in the previous 24 h. Given the risk of false positives for urine EtG and the excellent diagnostic performance of urine EtS, the measurement of urine EtS alone could be advocated. However, given the importance of correctly identifying whether a client is being truthful about their drinking and the availability of both test results when using a LC-MS/MS method, we recommend reporting both tests. Rather than replacing the breathalyser test with urine EtG and EtS, we propose making urine EtG/EtS an additional tool for the community alcohol treatment programmes. The advantage of a breathalyser test over laboratory analysis of urine for EtG and EtS is the immediate availability of the result which allows an immediate intervention for a client attending with a positive result. In community treatment programmes, previous studies have identified that those relapsing may be less likely to attend future sessions so the breathalyser test is still recommended with a urine sample collected in those claiming not to drink alcohol and a negative breathalyser result (Junghanns et al., 2009; Dahl et al., 2011) . These EtG and EtS results would need to be available to the team prior to the client's next visit one week later so a quick turnaround time from the laboratory is required. Availability of rapid point-of-care tests for EtG and particularly EtS may be useful for the community teams in future. We propose using urine EtG and EtS in conjunction with the alcohol diary and breathalyser test according to the flowchart shown in Fig. 2 . This pathway also provides interpretive comments for EtG and EtS based on the clinical cut-offs used in this study. If only urine EtG is positive, results need to be interpreted with caution but if only EtS is positive, this is consistent with recent alcohol consumption. Using these tests routinely will detect more clients in alcohol treatment that are continuing to drink alcohol and choosing not to disclose this information. This information will allow the initiation of earlier interventions and alternative treatment strategies. Ultimately, this could help to improve the numbers that successfully complete their treatment programmes and are free of dependence. This proposed pathway requires validation in a community alcohol treatment programme setting to demonstrate improved outcomes when using these tests. A randomized controlled trial comparing the outcomes of clients in alcohol treatment with or without the use of urine EtG and EtS is required.
CONCLUSION
Clients in community alcohol treatment were recruited. In comparison to a diary of alcohol intake, urine EtG and EtS were able to detect all participants continuing to consume alcohol in the previous 24 h. All four markers had excellent diagnostic specificity for alcohol intake. A combination of tests including immediate availability of breath ethanol and collection of urine for EtG and EtS will increase relapse detection in clients in community alcohol treatment. Detection of continued alcohol intake could lead to initiation of early intervention and altered treatment strategies which could improve the numbers of clients successfully completing treatment.
SUPPLEMENTARY MATERIAL
